Spring 2026 Co-op: Clinical Trials Operations at Prime Medicine

Watertown, Massachusetts, United States

Prime Medicine Logo
Not SpecifiedCompensation
InternshipExperience Level
InternshipJob Type
UnknownVisa
Biotechnology, PharmaceuticalsIndustries

Requirements

  • B.S or B.A. candidate for Biology or a Health sciences field, or similar
  • Excellent analytical and written and oral communication skills
  • Ability to work independently and as part of a team
  • Comfort with basic statistical concepts
  • Local to the Boston/Cambridge area

Responsibilities

  • Learning from and assisting the operations team in managing clinical trials
  • Participate in internal and external cross-functional study meetings; assist with meeting preparation, scheduling, and meeting minute taking and review
  • Communicate with study sites to assist with patient visit scheduling, ensuring necessary study materials are delivered on time, patient sample tracking, and ensuring data entry is on-track for study deliverables
  • Assist with maintaining study files, updating study materials (patient brochures, Informed Consent Forms, study manuals), and tracking of study deliverables and activities

Skills

Biology
Clinical Trials
Gene Therapy
Clinical Operations
Cross-functional Collaboration

Prime Medicine

Gene editing technology for genetic diseases

About Prime Medicine

Prime Medicine focuses on gene editing, specifically using a technology called Prime Editing to make precise changes to DNA. This technology can identify and fix faulty DNA segments, which helps restore normal genetic function. The company aims to cure, halt, or prevent genetic diseases, providing long-term benefits to patients. Prime Medicine targets individuals with genetic disorders, a significant market globally. Unlike many competitors, it emphasizes collaboration with research institutions and pharmaceutical companies to advance its technology and bring it to market through licensing agreements and partnerships. The leadership team has extensive experience in developing innovative medicines, and the company is committed to enhancing its technological capabilities.

Cambridge, MassachusettsHeadquarters
2019Year Founded
$306.4MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
201-500Employees

Benefits

Flexible Work Hours

Risks

Intellectual property disputes may lead to costly legal battles and delays.
The competitive landscape in gene editing is intensifying, challenging Prime Medicine's market position.
Reliance on partnerships exposes Prime Medicine to risks if collaborations don't meet expectations.

Differentiation

Prime Editing offers precise DNA modifications without double-stranded breaks, unlike CRISPR.
Prime Medicine's technology can correct faulty DNA segments, restoring normal genetic function.
The company collaborates with top-tier partners like Bristol Myers Squibb for strategic growth.

Upsides

Prime Medicine secured $244.6M to advance its genetic therapies and pipeline.
The partnership with Bristol Myers Squibb includes potential milestone payments over $3.5 billion.
Growing interest in gene editing for rare diseases boosts investment and collaboration opportunities.

Land your dream remote job 3x faster with AI